LSB — LakeShore Biopharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for LakeShore Biopharma Co, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	392	274	374	250	31.4
Net Total Accounts Receivable
Net Total Receivables	248	313	468	447	502
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	733	765	1,036	903	842
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	253	565	583	481	414
Net Intangible Assets
Other Long Term Assets
Total Assets	1,167	1,442	1,720	1,513	1,368
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	345	476	659	802	825
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	391	771	991	928	868
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	777	671	728	585	500
Total Liabilities & Shareholders' Equity	1,167	1,442	1,720	1,513	1,368
Total Common Shares Outstanding